Physicians’ awareness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer carcinomatosis | Zendy

Gillian Spiegle | Zendy; Selina Schmocker | Zendy; Harden Huang | Zendy; J. Charles Victor | Zendy; Calvin Law | Zendy; J. Andrea McCart | Zendy; Erin Kennedy | Zendy

Open Access

Physicians’ awareness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer carcinomatosis

Author(s) -

Gillian Spiegle,

Selina Schmocker,

Harden Huang,

J. Charles Victor,

Calvin Law,

J. Andrea McCart,

Erin Kennedy

Publication year - 2013

Publication title -

canadian journal of surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.609

H-Index - 64

eISSN - 1488-2310

pISSN - 0008-428X

DOI - 10.1503/cjs.003912

Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , colorectal cancer , peritoneal carcinomatosis , cytoreductive surgery , multivariate analysis , stage (stratigraphy) , intraperitoneal chemotherapy , general surgery , oncology , cancer , ovarian cancer , paleontology , biology

Recent trials have shown that cytoreductive surgery and heated intraperitoneal chemotherapy (S+HIPEC) for colorectal cancer carcinomatosis (CRC-C) leads to 5-year, disease-free survival rates of more than 30%. Since these data represent a substantial change in the management of CRC-C, the objectives of this study were to determine physicians' awareness of S+HIPEC for CRC-C and physician characteristics predictive of awareness of S+HIPEC for CRC-C.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research